Boothbay Fund Management, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

  • $4.17 Billion
  • Q1 2024

Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
SELL
$93.7 - $141.53 $13.3 Million - $20.2 Million
-142,400 Reduced 29.99%
332,500 $43 Million
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $16.8 Million - $31.2 Million
250,300 Added 111.44%
474,900 $45.8 Million
Q3 2023

Nov 14, 2023
BUY
$102.5 - $123.59 $22.6 Million - $27.2 Million
220,200 Added 5004.55%
224,600 $27.2 Million
Q2 2023

Aug 14, 2023
SELL
$106.4 - $157.19 $4.06 Million - $6 Million
-38,200 Reduced 89.67%
4,400 $503,000
Q1 2023

May 15, 2023
BUY
$117.53 - $155.99 $5.01 Million - $6.65 Million
42,600 New
42,600 $5.87 Million
Q3 2022

Nov 14, 2022
SELL
$75.71 - $119.24 $90,851 - $143,088
-1,200 Reduced 9.45%
11,500 $1.27 Million
Q2 2022

Aug 15, 2022
BUY
$62.69 - $88.44 $796,163 - $1.12 Million
12,700 New
12,700 $952,000
Q1 2022

May 16, 2022
SELL
$63.15 - $90.42 $2.72 Million - $3.89 Million
-43,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$77.28 - $99.42 $540,960 - $695,940
7,000 Added 19.44%
43,000 $3.87 Million
Q3 2021

Nov 15, 2021
BUY
$65.97 - $92.48 $2.01 Million - $2.81 Million
30,400 Added 542.86%
36,000 $3.33 Million
Q2 2021

Aug 16, 2021
BUY
$69.38 - $86.75 $388,528 - $485,800
5,600 New
5,600 $435,000

Others Institutions Holding SRPT

# of Institutions
470
Shares Held
79.3M
Call Options Held
4.23M
Put Options Held
1.21M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.8B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email